Kurt Possinger
Impact in
- Oncology top 1%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Bone health and treatments
- Hematology top 2%
- Multiple Myeloma Research and Treatments
Papers in
- Oncology 43
- Cancer Treatment and Pharmacology 14
- HER2/EGFR in Cancer Research 8
- Bone health and treatments 7
-
- Ubiquitin and proteasome pathways 9
- Peroxisome Proliferator-Activated Receptors 8
- Co-authors
- Orhan Sezer (36 shared papers)Jan Eucker (34 shared papers)Christian Jakob (22 shared papers)Ivana Zavrski (20 shared papers)Diana Lüftner (10 shared papers)Chuanbing Zang (16 shared papers)Ulrike Heider (20 shared papers)Patrice Herait (1 shared paper)
- Journals
- Blood (9 papers)Anti-Cancer Drugs (9 papers)Journal of Clinical Oncology (6 papers)European Journal Of Haematology (5 papers)Journal of Cancer Research and Clinical Oncology (4 papers)
- Partner nations
- GermanyUnited StatesFrance
In The Last Decade
Kurt Possinger
101 papers receiving 4.4k citations
Kurt Possinger's Hit Papers
Peers
Comparison fields: 5 of 133
- Oncology 1.8k
- Hematology 466
- Cancer Research 473
- Biological Psychiatry 77
- Hepatology 190
Countries citing papers authored by Kurt Possinger
This map shows the geographic impact of Kurt Possinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kurt Possinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kurt Possinger more than expected).
Fields of papers citing papers by Kurt Possinger
This network shows the impact of papers produced by Kurt Possinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kurt Possinger. The network helps show where Kurt Possinger may publish in the future.
Co-authors
The 25 scholars most cited alongside Kurt Possinger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 102 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer Hit paper breakdown → | 1998 | 822 |
| 2 | 2008 | 388 | |
| 3 | 2006 | 325 | |
| 4 | 2002 | 204 | |
| 5 | 2001 | 140 | |
| 6 | 2003 | 135 | |
| 7 | Expression of receptor activator of nuclear factor kappaB ligand on bone marrow plasma cells correlates with osteolytic bone disease in patients with multiple myeloma. | 2003 | 122 |
| 8 | 2006 | 114 | |
| 9 | 2008 | 112 | |
| 10 | Metformin and the mTOR inhibitor everolimus (RAD001) sensitize breast cancer cells to the cytotoxic effect of chemotherapeutic drugs in vitro. | 2012 | 89 |
| 11 | 2000 | 81 | |
| 12 | 2005 | 79 | |
| 13 | 2012 | 73 | |
| 14 | 2005 | 70 | |
| 15 | 2007 | 68 | |
| 16 | 2001 | 65 | |
| 17 | 1996 | 65 | |
| 18 | 2005 | 60 | |
| 19 | 2004 | 59 | |
| 20 | 2010 | 59 |
About Kurt Possinger
Kurt Possinger is a scholar working on Oncology, Molecular Biology, Hematology, Genetics and Cancer Research, having authored 102 papers that have together received 4.7k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (14 papers), Multiple Myeloma Research and Treatments (10 papers), Ubiquitin and proteasome pathways (9 papers), HER2/EGFR in Cancer Research (8 papers), Peroxisome Proliferator-Activated Receptors (8 papers), Estrogen and related hormone effects (7 papers), Bone health and treatments (7 papers) and Chronic Lymphocytic Leukemia Research (7 papers). The work is most often cited by research in Oncology (1.8k citations), Hematology (466 citations), Cancer Research (473 citations), Biological Psychiatry (77 citations) and Hepatology (190 citations). Kurt Possinger has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Orhan Sezer, Jan Eucker, Christian Jakob, Ivana Zavrski, Diana Lüftner, Chuanbing Zang, Ulrike Heider, Patrice Herait, Rudolf Morant and N. Niederle. Their work appears in journals such as Blood, Anti-Cancer Drugs, Journal of Clinical Oncology, European Journal Of Haematology and Journal of Cancer Research and Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.